ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Idaho » Nurse Practitioner, Family

Top Nurse Practitioner, Family Prescribers in Idaho

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VALERIE THOMSON FNP-C

Nurse Practitioner, Family

104

$13.4K

25
14 are 65+

68%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 22%

$129
Average prescription price

Avg: $78

GUSTIN BLAD FNP-BC

Nurse Practitioner, Family

132

$4,203

84
66 are 65+

68%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$32
Average prescription price

Avg: $78

CHRISTIAN GELOK CNP

Nurse Practitioner, Family

171

$4,527

102
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 22%

$26
Average prescription price

Avg: $78

GARY HURST ARNP

Nurse Practitioner, Family

390

$31.9K

121
73 are 65+

28%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $78

JOSIE FARMER

Nurse Practitioner, Family

450

$17.6K

109
83 are 65+

44%
patients receiving schedule two controlled substances

Avg: 8%

32%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$39
Average prescription price

Avg: $78

DAVID FOSS FNP

Nurse Practitioner, Family

488

$26.9K

63
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $78

RYAN PARK NP

Nurse Practitioner, Family

507

$29.6K

163
34 are 65+

81%
patients receiving schedule two controlled substances

Avg: 8%

34%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $78

KELLY WHITEHEAD-PRICE NP-C

Nurse Practitioner, Family

522

$16K

289
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

4%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$31
Average prescription price

Avg: $78

LESLIE ROGERS NP

Nurse Practitioner, Family

542

$16.8K

180
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$31
Average prescription price

Avg: $78

CYNTHIA BOULTON NP

Nurse Practitioner, Family

544

$36.8K

120
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $78

JENNIFER GOODING N.P.-C.

Nurse Practitioner, Family

607

$63.8K

148
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$105
Average prescription price

Avg: $78

MARGARET MORTIMER NP

Nurse Practitioner, Family

687

$22.6K

97
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$33
Average prescription price

Avg: $78

KATHERINE REED APRN

Nurse Practitioner, Family

716

$34.1K

231
202 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

46%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $78

SCARLETT UHLENKOTT NP

Nurse Practitioner, Family

731

$340K

121
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$465
Average prescription price

Avg: $78

TARYNA GOODMAN NP

Nurse Practitioner, Family

743

$24.9K

93
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$34
Average prescription price

Avg: $78

STACEY WRIGHT NP

Nurse Practitioner, Family

760

$170K

77
0 are 65+

38%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 22%

$224
Average prescription price

Avg: $78

AMBER MASSE NP

Nurse Practitioner, Family

766

$49.1K

132
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $78

NICKI PETERS NP-C

Nurse Practitioner, Family

803

$69K

40
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$86
Average prescription price

Avg: $78

LYNDA MARICLE-KUWAHARA APRN-C

Nurse Practitioner, Family

820

$53.2K

62
33 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

35%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $78

CYNTHIA CULP FNP

Nurse Practitioner, Family

857

$54K

54
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $78

ELLEN TAYLOR ARNP

Nurse Practitioner, Family

878

$18.2K

503
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 22%

$21
Average prescription price

Avg: $78

LAURA MASON NP

Nurse Practitioner, Family

881

$50.7K

63
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $78

TIFFANY KUGLER NP

Nurse Practitioner, Family

971

$36.6K

55
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$38
Average prescription price

Avg: $78

JEREMY BASSE FNP

Nurse Practitioner, Family

975

$80.6K

163
119 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$83
Average prescription price

Avg: $78

SAMANTHA GALLEGOS GNP

Nurse Practitioner, Family

995

$57.1K

193
170 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $78

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank